Almirall Eyes Top Specialty Dermatology Role After its AstraZeneca Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Spain’s leading pharma company will use proceeds of its respiratory products sale to bulk up in dermatology, with the aim of becoming a global leader in the sector.